Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Samsrita LabsBOM:539267 +4.97%18 PB Ratio is 2.21 as of Aug. 08, 2026, which is 38% below its 10-year median of 3.59. GuruFocus rates BOM:539267 with a GF Score™ of 18/100. The stock has 3 warning signs investors should review. Among 195 Medical Diagnostics & Research companies, Samsrita Labs ranks better than 51.28% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-08), Samsrita Labs's share price is ₹11.41. Samsrita Labs's Book Value per Share for the quarter that ended in Mar. 2026 was ₹5.17. Hence, Samsrita Labs's PB Ratio of today is 2.21.
Good Sign:
Samsrita Labs Ltd stock PB Ratio (=2.39) is close to 2-year low of 2.26.
The historical rank and industry rank for Samsrita Labs's PB Ratio or its related term are showing as below:
BOM:539267'
s PB Ratio Range Over the Past 10 Years
Min: 1.8 Med: 3.59 Max: 8.92
Current: 2.17
During the past 12 years, Samsrita Labs's highest PB Ratio was 8.92. The lowest was 1.80. And the median was 3.59.
BOM:539267's PB Ratio is ranked better than 51.28% of 195
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.11
vs BOM:539267: 2.17
During the past 12 months, Samsrita Labs's average Book Value Per Share Growth Rate was -36.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -15.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -6.10% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -1.60% per year.
During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Samsrita Labs was 11.10% per year. The lowest was -15.10% per year. And the median was 1.20% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Samsrita Labs PB Ratio Related Terms
Samsrita Labs PB Ratio Historical Data
* Premium members only.
The historical data trend for Samsrita Labs's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Samsrita Labs's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Samsrita Labs PB Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Samsrita Labs's PB Ratio distribution charts can be found below:
* The bar in red indicates where Samsrita Labs's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Samsrita Labs's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Samsrita Labs (BOM:539267) has a PB Ratio of 2.21 as of Aug. 08, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Samsrita Labs and its competitors. This is 38% below median its historical median of 3.59. Over the past decade, Samsrita Labs' PB Ratio has ranged from 1.80 to 8.92. According to the industry distribution chart, Samsrita Labs ranks #95 out of 195 companies in the Medical Diagnostics & Research industry, placing it in the top 48.7%.
Is Samsrita Labs' PB Ratio too high?
Samsrita Labs' current PB Ratio of 2.21 is 38% below median its 10-year median of 3.59. Over the past 10 years, this metric has ranged from a low of 1.80 to a high of 8.92. The Medical Diagnostics & Research industry median PB Ratio is 2.11. Samsrita Labs' value of 2.21 is 4.7% above this industry median. Based on the distribution chart, Samsrita Labs ranks #95 out of 195 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Samsrita Labs has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Samsrita Labs' PB Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Samsrita Labs ranks #95 out of 195 companies for PB Ratio. This puts Samsrita Labs in the upper half of its industry. The industry median PB Ratio is 2.11. Samsrita Labs' value of 2.21 is 4.7% above this benchmark. Historically, Samsrita Labs' own PB Ratio has ranged from 1.80 to 8.92 over the past decade. While the company's 10-year median is 3.59 vs. the industry median of 2.11, Samsrita Labs has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Diagnostics & Research company?
The median PB Ratio among Medical Diagnostics & Research companies is 2.11, based on 195 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Samsrita Labs's current PB Ratio of 2.21 is 4.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Samsrita Labs and its competitors. For the Medical Diagnostics & Research industry, the median PB Ratio is 2.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Samsrita Labs's current PB Ratio is 2.21, which is 38% below median its own 10-year median of 3.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Samsrita Labs stock overvalued right now?
Samsrita Labs (BOM:539267) has a current PB Ratio of 2.21. The current PB Ratio is 2.21, which is 38% below median its 10-year median of 3.59 and 4.7% above the Medical Diagnostics & Research industry median of 2.11. Samsrita Labs' overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Samsrita Labs (BOM:539267), the current PB Ratio is 2.21 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Samsrita Labs Ltd is an India based diversified healthcare company. The company's operations include research and excellence in the areas of Stem cell research and development and therapy, New drug discovery, Diagnostics and Bio Lab, Pharmacy, Out-Patient Consultancy Division in name of ORIGIN HOSPITALS, and Research and Development in Biotechnology. It has one reportable segment namely, healthcare services including hospital, diagnostics, Pharma, and Biotechnology.
18GF Score
Get the complete analysis for BOM:539267
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:539267 has been successfully added to your 
